Consistently, Western blot results demonstrated that, relative to the PBS, CuZCeP@NC, and Sono@NC groups, tumor tissues from the Sono@NAT10 group exhibited significantly lower NAT10 and SRSF2 expression, accompanied by a notable upregulation of HDAC10 (Figure S8C, Supporting Information). This evidence concerns the gene SRSF2 and neoplasm.